All Episodes
Gut Podcast — 129 episodes
Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
Managing type 2 diabetes patients with MASLD
Targeting MASLD with new nanoparticles
Performance of the China-CLIF framework in acute-on-chronic liver failure
Predicting short-term liver transplant outcomes with graft microbial DNA signature
Screening and eradication of H pylori for gastric cancer prevention: Taipei Global Consensus II
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions
Effective treatment of severe acute pancreatitis using COX-2 inhibitors
Protecting against Crohn's disease with dietary whey protein
Comparing diclofenac and indomethacin for prevention of post-ERCP pancreatitis
Studying oat ingestion in coeliac disease with purified oat protein
Predicting sensitivity to dietary emulsifiers using an in-vitro microbiota model
Antiviral treatment of chronic Hepatitis B
Single-cell spatial profiling of immunotypes in hepatocellular carcinoma
Understanding the gut-adipose-liver axis and its impact on insulin action
Linking breastfeeding and atopic dermatitis in infants
Improving CLDN18.2 BiTEs efficacy against pancreatic cancer
Gut microbiota signatures of vulnerability to food addiction in mice and humans
Gastric intestinal metaplasia: reviewing current guidelines
Exploring stem cell therapy for Hirschsprung disease
Protective function of sclerosing cholangitis on IBD
Linking high-fat diet and liver tumorigenesis
Hepatocellular carcinoma in patients with liver cirrhosis
Microbiome interventions for COPD protection
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
RE.GA.IN: the Real-world Gastritis Initiative
Prebiotic diet changes neural correlates of food decision-making in overweight adults
Lethal sepsis prevention with novel tripeptide RKH derived from Akkermansia muciniphila
Special Gut Podcast: Digestive health and climate change
Gastrointestinal origins for Parkinson’s disease
Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
Rome consensus on gut microbiota and faecal microbiota transplantation in IBD
The therapeutic potential of fasting
Helicobacter pylori promotes colorectal carcinogenesis
Single-cell transcriptomics sheds new light on pancreas biology and disease
Counteracting the harm of dietary emulsifiers with Akkermansia muciniphila
Antibiotic use as a risk factor for IBD
Predicting disease progression in bridging fibrosis and cirrhosis with liver stiffness
Assessing the impact of dietary fibre on bile acid transformation by gut bacteria in mice
Autoimmune gastritis: cancer risk in consistently tested H. pylori-negative patients
FMT-AID trial shows effectiveness in inducing remission of ulcerative colitis
Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis
Climate change: a survey of global gastroenterology society leadership
Management of Helicobacter pylori infection — the Maastricht VI/Florence Consensus Report
Kyoto international consensus report on the gastro-oesophageal junction
A faecal microbiota signature with high specificity for pancreatic cancer
PICaSSO Histologic Remission Index in ulcerative colitis: a novel simplified histological score
Next-generation sequencing of bile cell-free DNA for early detection of malignant biliary strictures
Endoscopic full-thickness plication for the treatment of PPI-dependent GERD
Dysosmobacter welbionis, a new human commensal bacterium preventing diet-induced obesity
Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Pg-LPS
Proton pump inhibitors and risk of colorectal cancer
Sugar-sweetened beverage intake and risk of early-onset colorectal cancer among women
Diet quality and risk and severity of COVID-19: a prospective cohort study
Helicobacter pylori resistance to antibiotics in Europe
Blue poo: impact of gut transit time on the gut microbiome using a novel marker
Long-term dietary patterns associated with inflammatory features of the gut microbiome
Association between Brachyspira and irritable bowel syndrome with diarrhoea
Effect of IBD medications on COVID-19 outcomes
CLARITY IBD: Anti-SARS-CoV-2 antibody and vaccination responses in patients treated with infliximab
Long-term instability of the intestinal microbiome and its associations
Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis
Screening and eradication of Helicobacter pylori for gastric cancer prevention
European Registry on Helicobacter pylori management (Hp-EuReg)
Driving the efficacy of prebiotic intervention in obese patients
Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Efficacy of FMT for patients with IBS in a randomised, double-blind, placebo-controlled study
Infants born to mothers with IBD present with altered gut microbiome
Mediterranean diet intervention alters the gut microbiome in older people
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus
British Society of Gastroenterology guidance for management of IBD during the Covid-19 pandemic
Global patterns and trends in colorectal cancer incidence in young adults
Guidelines on the management of inflammatory bowel disease in adults
European evidence-based guidelines on pancreatic cystic neoplasms
Viral transfer during FMT linked to better outcomes in recurrent C. diff bacterial infections
Colorectal cancer: research prioritisation needed in third most lethal malignancy worldwide
Development of an FGF19-based chimeric molecule to promote fatty liver regeneration
Feeding the microbiota: transducer of nutrient signals for the host
Dietary emulsifiers directly alter human microbiota composition
Faecal microbiota transplantation in clinical practice
BMP-9 interferes with liver regeneration and promotes liver fibrosis
A systematic review of isolated colonic Crohn’s disease: the third IBD?
Gut microbiome and liver diseases
Antibiotics as deep modulators of gut microbiota: between good and evil.
Asia-Pacific consensus on the management of gastro-oesophageal reflux disease
Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma
Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn’s disease
GLP-1 based therapies: clinical implications for gastroenterologists
Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis
Mesalazine and thymoquinone attenuate intestinal tumour development in mice
Effects of bowel cleansing on the intestinal microbiota
Development of an enhanced human gastrointestinal epithelial culture system
Helicobacter pylori targets cancer-associated apical-junctional constituents
Diagnosis and management of acute kidney injury in patients with cirrhosis
Demonstration of the usefulness of epigenetic cancer risk prediction
XIAP variants in male Crohn’s disease
Cell lineage distribution atlas reveals heterogeneous gland populations in the gastric antrum
Classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
Update on basic and clinical aspects of eosinophilic oesophagitis
AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition
Besifovir versus entecavir in Asian patients with chronic hepatitis B
Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea
Recent advances in clinical practice challenges and opportunities in the management of obesity
Amniotic stem cell treament for necrotic enterocolitis
British Society of Gastroenterology guidelines on diagnosing and managing Barrett’s oesophagus
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients
A systematic approach to therapeutic target selection in oesophago-gastric cancer
Gut podcast: Treatment of pancreatic fibrosis with siRNA
Intra-tumoural stroma as a predictor of survival in patients with gastric cancer
Probiotics in health and disease
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission
mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway
Endoscopic improvement of mucosal lesions in patients with ileocolonic Crohn’s disease
Bowel cancer screening in England
PUFAS and neoplasms
Cancer treatment induced gastrointestinal symptoms
Bifidobacterium and gastrointestinal inflammation
High-fat diet and gut microbiota
Management of Helicobacter pylori infection
Assessment of colorectal cancer molecular features
Probiotic and postbiotic activity in health and disease
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
Outcomes of the Bowel Cancer Screening Programme in England
Mucosal healing in inflammatory bowel disease
Interleukin 13 and its role in gut defence and inflammation
Revising the classification of acute pancreatitis